PLA2G4D

Across TCGA pan-cancer cohorts, PLA2G4D mass-spec protein is linked to patient survival in 2 of 34 cancer types, making it a survival-associated PLA2G4D data layer compared with 24 for mass-spec protein and 6 for mutation status.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher PLA2G4D mass-spec protein is associated with better overall survival. In most high-consensus cancer types, elevated PLA2G4D expression acts as an unfavorable survival marker, although some lineages such as HNSC and UCEC show a favorable association.

HNSC and UCEC are the cancer types where PLA2G4D mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Tertile	II,III,IV	0.892	0.610	.012	20	view →
UCEC	DFS	Median	All	1.000	0.467	.015	4	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

PLA2G4D–HNSC (OS)

Open the HNSC breakdown →